What happened
Edison Scientific, an AI startup spun out of FutureHouse, secured $70 million in funding, led by Spark Capital, Triatomic Capital, and an unnamed biotech investor, with additional participation from Jeff Dean and Dmitri Alperovitch. The company is developing an AI scientist platform, Kosmos, designed to automate and expedite scientific research processes. This platform facilitates literature review, data analysis, hypothesis generation, and molecular design, aiming to identify therapeutic targets and elucidate complex molecular structures. Edison Scientific will offer a free tier alongside paid features for power users.
Why it matters
The introduction of Edison Scientific's AI scientist platform, Kosmos, increases operational exposure for research and development (R&D) teams and procurement to AI-driven scientific processes. This necessitates higher due diligence requirements for validating AI-generated research outputs, ensuring data provenance, and managing intellectual property associated with AI-designed molecules or hypotheses. Compliance and IT security teams face an increased oversight burden regarding data handling and the integration of external AI tools into existing research workflows, particularly concerning the free tier's potential unmonitored usage.
Subscribe for Weekly Updates
Stay ahead with our weekly AI and tech briefings, delivered every Tuesday.
